 | • レポートコード：QYR2104Z3526 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、黄斑浮腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（レーザー治療、抗VEGF注射、抗炎症治療、硝子体切除術）、用途別市場規模（嚢胞性黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・黄斑浮腫治療の市場動向 ・企業の競争状況、市場シェア ・黄斑浮腫治療の種類別市場規模（レーザー治療、抗VEGF注射、抗炎症治療、硝子体切除術） ・黄斑浮腫治療の用途別市場規模（嚢胞性黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME）） ・黄斑浮腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・黄斑浮腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・黄斑浮腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・黄斑浮腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・黄斑浮腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Novartis、Roche、Regeneron Pharmaceuticals、Pfizer、Bayer、Boehringer Ingelheim、Bausch & Lomb、Aciont、ActiveSite Pharmaceuticals、Adverum Biotechnologies、Aerpio Therapeutics、Ampio Pharmaceuticals、Araim Pharmaceuticals、Astellas Pharma） ・結論 |
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.
Market Analysis and Insights: Global Macular Edema Therapeutics Market
The global Macular Edema Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Macular Edema Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Macular Edema Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Macular Edema Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Macular Edema Therapeutics market.
Global Macular Edema Therapeutics Scope and Market Size
Macular Edema Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Macular Edema Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy
Segment by Application
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
Regeneron Pharmaceuticals
Pfizer
Aerpio Therapeutics
Ampio Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laser Treatment
1.2.3 Anti-VEGF Injection
1.2.4 Anti-Inflammatory Treatment
1.2.5 Vitrectomy
1.3 Market by Application
1.3.1 Global Macular Edema Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cystoid Macular Edema (CME)
1.3.3 Diabetic Macular Edema(DME)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Macular Edema Therapeutics Market Perspective (2016-2027)
2.2 Macular Edema Therapeutics Growth Trends by Regions
2.2.1 Macular Edema Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Macular Edema Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Macular Edema Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Macular Edema Therapeutics Industry Dynamic
2.3.1 Macular Edema Therapeutics Market Trends
2.3.2 Macular Edema Therapeutics Market Drivers
2.3.3 Macular Edema Therapeutics Market Challenges
2.3.4 Macular Edema Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macular Edema Therapeutics Players by Revenue
3.1.1 Global Top Macular Edema Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Macular Edema Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Macular Edema Therapeutics Revenue
3.4 Global Macular Edema Therapeutics Market Concentration Ratio
3.4.1 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macular Edema Therapeutics Revenue in 2020
3.5 Macular Edema Therapeutics Key Players Head office and Area Served
3.6 Key Players Macular Edema Therapeutics Product Solution and Service
3.7 Date of Enter into Macular Edema Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Macular Edema Therapeutics Breakdown Data by Type
4.1 Global Macular Edema Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Macular Edema Therapeutics Forecasted Market Size by Type (2022-2027)
5 Macular Edema Therapeutics Breakdown Data by Application
5.1 Global Macular Edema Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Macular Edema Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Macular Edema Therapeutics Market Size (2016-2027)
6.2 North America Macular Edema Therapeutics Market Size by Type
6.2.1 North America Macular Edema Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Macular Edema Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Macular Edema Therapeutics Market Size by Type (2016-2027)
6.3 North America Macular Edema Therapeutics Market Size by Application
6.3.1 North America Macular Edema Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Macular Edema Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Macular Edema Therapeutics Market Size by Application (2016-2027)
6.4 North America Macular Edema Therapeutics Market Size by Country
6.4.1 North America Macular Edema Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Macular Edema Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Macular Edema Therapeutics Market Size (2016-2027)
7.2 Europe Macular Edema Therapeutics Market Size by Type
7.2.1 Europe Macular Edema Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Macular Edema Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Macular Edema Therapeutics Market Size by Type (2016-2027)
7.3 Europe Macular Edema Therapeutics Market Size by Application
7.3.1 Europe Macular Edema Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Macular Edema Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Macular Edema Therapeutics Market Size by Application (2016-2027)
7.4 Europe Macular Edema Therapeutics Market Size by Country
7.4.1 Europe Macular Edema Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Macular Edema Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Macular Edema Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Macular Edema Therapeutics Market Size by Type
8.2.1 Asia-Pacific Macular Edema Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Macular Edema Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Macular Edema Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Macular Edema Therapeutics Market Size by Application
8.3.1 Asia-Pacific Macular Edema Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Macular Edema Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Macular Edema Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Macular Edema Therapeutics Market Size by Region
8.4.1 Asia-Pacific Macular Edema Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Macular Edema Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Macular Edema Therapeutics Market Size (2016-2027)
9.2 Latin America Macular Edema Therapeutics Market Size by Type
9.2.1 Latin America Macular Edema Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Macular Edema Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Macular Edema Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Macular Edema Therapeutics Market Size by Application
9.3.1 Latin America Macular Edema Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Macular Edema Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Macular Edema Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Macular Edema Therapeutics Market Size by Country
9.4.1 Latin America Macular Edema Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Macular Edema Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macular Edema Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Macular Edema Therapeutics Market Size by Type
10.2.1 Middle East & Africa Macular Edema Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Macular Edema Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Macular Edema Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Macular Edema Therapeutics Market Size by Application
10.3.1 Middle East & Africa Macular Edema Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Macular Edema Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Macular Edema Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Macular Edema Therapeutics Market Size by Country
10.4.1 Middle East & Africa Macular Edema Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Macular Edema Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Macular Edema Therapeutics Introduction
11.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Macular Edema Therapeutics Introduction
11.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Macular Edema Therapeutics Introduction
11.3.4 Roche Revenue in Macular Edema Therapeutics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Macular Edema Therapeutics Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021)
11.4.5 Regeneron Pharmaceuticals Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Macular Edema Therapeutics Introduction
11.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Macular Edema Therapeutics Introduction
11.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Macular Edema Therapeutics Introduction
11.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2016-2021)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Bausch & Lomb
11.8.1 Bausch & Lomb Company Details
11.8.2 Bausch & Lomb Business Overview
11.8.3 Bausch & Lomb Macular Edema Therapeutics Introduction
11.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2016-2021)
11.8.5 Bausch & Lomb Recent Development
11.9 Aciont
11.9.1 Aciont Company Details
11.9.2 Aciont Business Overview
11.9.3 Aciont Macular Edema Therapeutics Introduction
11.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2016-2021)
11.9.5 Aciont Recent Development
11.10 ActiveSite Pharmaceuticals
11.10.1 ActiveSite Pharmaceuticals Company Details
11.10.2 ActiveSite Pharmaceuticals Business Overview
11.10.3 ActiveSite Pharmaceuticals Macular Edema Therapeutics Introduction
11.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021)
11.10.5 ActiveSite Pharmaceuticals Recent Development
11.11 Adverum Biotechnologies
11.11.1 Adverum Biotechnologies Company Details
11.11.2 Adverum Biotechnologies Business Overview
11.11.3 Adverum Biotechnologies Macular Edema Therapeutics Introduction
11.11.4 Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2016-2021)
11.11.5 Adverum Biotechnologies Recent Development
11.12 Aerpio Therapeutics
11.12.1 Aerpio Therapeutics Company Details
11.12.2 Aerpio Therapeutics Business Overview
11.12.3 Aerpio Therapeutics Macular Edema Therapeutics Introduction
11.12.4 Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2016-2021)
11.12.5 Aerpio Therapeutics Recent Development
11.13 Ampio Pharmaceuticals
11.13.1 Ampio Pharmaceuticals Company Details
11.13.2 Ampio Pharmaceuticals Business Overview
11.13.3 Ampio Pharmaceuticals Macular Edema Therapeutics Introduction
11.13.4 Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021)
11.13.5 Ampio Pharmaceuticals Recent Development
11.14 Araim Pharmaceuticals
11.14.1 Araim Pharmaceuticals Company Details
11.14.2 Araim Pharmaceuticals Business Overview
11.14.3 Araim Pharmaceuticals Macular Edema Therapeutics Introduction
11.14.4 Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021)
11.14.5 Araim Pharmaceuticals Recent Development
11.15 Astellas Pharma
11.15.1 Astellas Pharma Company Details
11.15.2 Astellas Pharma Business Overview
11.15.3 Astellas Pharma Macular Edema Therapeutics Introduction
11.15.4 Astellas Pharma Revenue in Macular Edema Therapeutics Business (2016-2021)
11.15.5 Astellas Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Macular Edema Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laser Treatment
Table 3. Key Players of Anti-VEGF Injection
Table 4. Key Players of Anti-Inflammatory Treatment
Table 5. Key Players of Vitrectomy
Table 6. Global Macular Edema Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Macular Edema Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Macular Edema Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Macular Edema Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Macular Edema Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Macular Edema Therapeutics Market Share by Regions (2022-2027)
Table 12. Macular Edema Therapeutics Market Trends
Table 13. Macular Edema Therapeutics Market Drivers
Table 14. Macular Edema Therapeutics Market Challenges
Table 15. Macular Edema Therapeutics Market Restraints
Table 16. Global Macular Edema Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Macular Edema Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Macular Edema Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Macular Edema Therapeutics as of 2020)
Table 19. Ranking of Global Top Macular Edema Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Macular Edema Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Macular Edema Therapeutics Product Solution and Service
Table 23. Date of Enter into Macular Edema Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Macular Edema Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Macular Edema Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Macular Edema Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Macular Edema Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Macular Edema Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Macular Edema Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Macular Edema Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Macular Edema Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Macular Edema Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Macular Edema Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Macular Edema Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Macular Edema Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Macular Edema Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Macular Edema Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Macular Edema Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Macular Edema Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Macular Edema Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Macular Edema Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Macular Edema Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Macular Edema Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Macular Edema Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Macular Edema Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Macular Edema Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Macular Edema Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Macular Edema Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Macular Edema Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Macular Edema Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Macular Edema Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Macular Edema Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Macular Edema Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Macular Edema Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Macular Edema Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Macular Edema Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Macular Edema Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Macular Edema Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Macular Edema Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Macular Edema Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Macular Edema Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Macular Edema Therapeutics Product
Table 66. Allergan Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Macular Edema Therapeutics Product
Table 71. Novartis Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Macular Edema Therapeutics Product
Table 76. Roche Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Regeneron Pharmaceuticals Company Details
Table 79. Regeneron Pharmaceuticals Business Overview
Table 80. Regeneron Pharmaceuticals Macular Edema Therapeutics Product
Table 81. Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Regeneron Pharmaceuticals Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Macular Edema Therapeutics Product
Table 86. Pfizer Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Macular Edema Therapeutics Product
Table 91. Bayer Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. Boehringer Ingelheim Company Details
Table 94. Boehringer Ingelheim Business Overview
Table 95. Boehringer Ingelheim Macular Edema Therapeutics Product
Table 96. Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Boehringer Ingelheim Recent Development
Table 98. Bausch & Lomb Company Details
Table 99. Bausch & Lomb Business Overview
Table 100. Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Bausch & Lomb Recent Development
Table 102. Aciont Company Details
Table 103. Aciont Business Overview
Table 104. Aciont Macular Edema Therapeutics Product
Table 105. Aciont Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Aciont Recent Development
Table 107. ActiveSite Pharmaceuticals Company Details
Table 108. ActiveSite Pharmaceuticals Business Overview
Table 109. ActiveSite Pharmaceuticals Macular Edema Therapeutics Product
Table 110. ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 111. ActiveSite Pharmaceuticals Recent Development
Table 112. Adverum Biotechnologies Company Details
Table 113. Adverum Biotechnologies Business Overview
Table 114. Adverum Biotechnologies Macular Edema Therapeutics Product
Table 115. Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Adverum Biotechnologies Recent Development
Table 117. Aerpio Therapeutics Company Details
Table 118. Aerpio Therapeutics Business Overview
Table 119. Aerpio Therapeutics Macular Edema Therapeutics Product
Table 120. Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 121. Aerpio Therapeutics Recent Development
Table 122. Ampio Pharmaceuticals Company Details
Table 123. Ampio Pharmaceuticals Business Overview
Table 124. Ampio Pharmaceuticals Macular Edema Therapeutics Product
Table 125. Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 126. Ampio Pharmaceuticals Recent Development
Table 127. Araim Pharmaceuticals Company Details
Table 128. Araim Pharmaceuticals Business Overview
Table 129. Araim Pharmaceuticals Macular Edema Therapeutics Product
Table 130. Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 131. Araim Pharmaceuticals Recent Development
Table 132. Astellas Pharma Company Details
Table 133. Astellas Pharma Business Overview
Table 134. Astellas Pharma Macular Edema Therapeutics Product
Table 135. Astellas Pharma Revenue in Macular Edema Therapeutics Business (2016-2021) & (US$ Million)
Table 136. Astellas Pharma Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Macular Edema Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Laser Treatment Features
Figure 3. Anti-VEGF Injection Features
Figure 4. Anti-Inflammatory Treatment Features
Figure 5. Vitrectomy Features
Figure 6. Global Macular Edema Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Cystoid Macular Edema (CME) Case Studies
Figure 8. Diabetic Macular Edema(DME) Case Studies
Figure 9. Macular Edema Therapeutics Report Years Considered
Figure 10. Global Macular Edema Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Macular Edema Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Macular Edema Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Macular Edema Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Macular Edema Therapeutics Market Share by Players in 2020
Figure 15. Global Top Macular Edema Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Macular Edema Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Macular Edema Therapeutics Revenue in 2020
Figure 17. Global Macular Edema Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Macular Edema Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Macular Edema Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Macular Edema Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Macular Edema Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Macular Edema Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Macular Edema Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Macular Edema Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Macular Edema Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Macular Edema Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Macular Edema Therapeutics Market Share by Region (2016-2027)
Figure 39. China Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Macular Edema Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Macular Edema Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Macular Edema Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Macular Edema Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Macular Edema Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Macular Edema Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Macular Edema Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 61. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 65. Bausch & Lomb Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 66. Aciont Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 67. ActiveSite Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 68. Adverum Biotechnologies Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 69. Aerpio Therapeutics Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 70. Ampio Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 71. Araim Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 72. Astellas Pharma Revenue Growth Rate in Macular Edema Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の糖尿病黄斑浮腫治療市場規模・現状・予測（2021年-2027年） Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Increasing prevalence of diabetes in the prime factor driving …- 世界の糖尿病黄斑浮腫治療市場規模・現状・予測（2021年-2027年） Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Increasing prevalence of diabetes in the prime factor driving …
- 世界の糖尿病黄斑浮腫治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diabetic Macular Edema Drug Market The global Diabetic Macular Edema Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の嚢胞様黄斑浮腫（CME）市場規模・現状・予測（2021年-2027年） Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disrupti…
- 世界の脳浮腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Brain Edema Treatment Market The global Brain Edema Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…